Abstract
Genital mycoplasmas are commonly found in the female genital tract. Despite ongoing debate, the evidence that they cause lower genital tract disease in women remains sparse. The data that Mycoplasma genitalium is primarily transmitted sexually are accumulating, but its role as a cause of symptomatic urethritis or cervicitis is open to debate. Although Mycoplasma hominis may be a co-factor in bacterial vaginosis, it has otherwise not been implicated as a cause of lower tract disease. Now that Ureaplasma urealyticum has been divided into U. urealyticum and Ureaplasma parvum, their role in causing urethritis and cervicitis remains even more unclear. To date, no convincing evidence exists that antimicrobial therapy should be directed solely at these organisms when treating women with urethritis, bacterial vaginosis, trichomoniasis, or cervicitis.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Haggerty CL, Totten PA, Astete SG, et al.: Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect 2008, 84:338–342.
Taylor-Robinson D: The role of mycoplasmas in pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007, 21:425–438.
Hartmann M: Genital mycoplasmas. J Dtsch Dermatol Ges 2009, 7:371–377.
Petrikkos GL, Hadjisoteriou M, Daikos GL: PCR versus culture in the detection of vaginal Ureaplasma urealyticum and Mycoplasma hominis. Int J Gynaecol Obstet 2007, 97:202–203.
• McIver CJ, Rismanto N, Smith C, et al.: Multiplex PCR testing detection of higher-than-expected Rates of cervical mycoplasma, ureaplasma, and trichomonas and viral agent infections in sexually active Australian women. J Clin Microbiol 2009, 47:1358–1363. This interesting article investigated the use of multiplex PCR to detect various STDs. One array in particular was used to detect the four bacteria discussed extensively in this article.
• Moi H, Reinton N, Moghaddam A: Mycoplasma genitalium in women with lower genital tract inflammation. Sex Transm Infect 2009, 85:10–14. This article investigates M. genitalium and its possible role in female urethritis with well-defined parameters.
Casin I, Vexiau-Robert D, De La Salmoniere P, et al.: High prevalence of Mycoplasma genitalium in the lower genitourinary tract of women attending a sexually transmitted disease clinic in Paris, France. Sex Transm Dis 2002, 29(6):353–359.
Tully JG, Taylor-Robinson D, Cole RM, Rose DL: A newly discovered Mycoplasma in the human urogenital tract. Lancet 1981, 1:1288–1291.
Falk L, Fredlund H, Jensen JS: Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect 2005, 81:73–78.
Tosh AK, Van Der Pol B, Fortenberry JD, et al.: Mycoplasma genitalium among adolescent women and their partners. J Adolesc Health 2007, 40:412–417.
Short VL, Totten PA, Ness RB, et al.: Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis 2009, 48:41–47.
Manhart LE, Critchlow CW, Holmes KK, et al: Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003, 187:650–657.
Korte JE, Baseman JB, Cagle MP, et al.: Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. Am J Reprod Immunol 2006, 55:265–275.
•• Gaydos C, Maldeis NE, Hardick A, et al.: Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis 2009, 36:598–606. A cross-sectional study investigating the prevalence of various STDs and their contribution to cervicitis. Data were well summarized and the authors noted a significant association between M. genitalium and cervicitis
Huppert JS, Mortensen JE, Reed JL, et al.: Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis 2008, 35(3):250–254.
Anagrius C, Lore B, Jensen JS: Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005, 81:458–462.
Keane FEA, Thomas BJ, Gilroy CB, et al.: The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners. Int J STD AIDS 2000, 11:356–360.
Taylor-Robinson D, Rosenstein IJ: Is Mycoplasma hominis a vaginal pathogen? Sex Transm Infect 2001, 77:302.
Sha BE, Chen HY, Wang QJ, et al.: Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol 2005, 43:4607–4612.
Srinivasan S, Fredricks DN: The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis 2008, 2008:750479.
Austin MN, Beigi RH, Meyn LA, Hillier SL: Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 2005, 43:4492–4497.
• Vancini RG, Pereira-Neves A, Borojevic, et al.: Trichomonas vaginalis harboring Mycoplasma hominis increases cytopathogenicity in vitro. Eur J Clin Microbiol Infect Dis 2008, 27:259–267. This article investigates that connection between M. hominis and T. vaginalis at the cellular level.
Mårdh PA, Elshibly S, Kallings I, Hellberg D: Vaginal flora changes associated with Mycoplasma hominis. Am J Obstet Gynecol 1997, 176:173–178.
Arya OP, Tong CY, Hart CA, et al.: Is Mycoplasma hominis a vaginal pathogen? Sex Transm Infect 2001, 77:58–62.
Kong F, James G, Zhenfang M, et al.: Phylogenetic analysis of Ureaplasma urealyticum-support for the establishment of a new species, Ureaplasma parvum. Int J Syst Bacter 1999, 49:1879–1889.
Nyirjesy P: Nongonococcal and nonchlamydial cervicitis. Cur Infect Dis Reports 2001, 3:540–545.
Schlicht MJ, Lovrich SD, Sartin JS, et al.: High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin. J Clin Microbiol 2004, 42:4636–4640.
• DeFrancesco MA, Negrini R, Pinsi G, et al.: Detection of Ureaplasma biovars and polymerase chain reaction-based subtyping of Ureaplasma parvum in women with or without symptoms of genital infections. Eur J Clin Microbiol Infect Dis 2009, 28:641–646. The authors investigated the two ureaplasma biovars and suggest differentiating further by strains suspecting a difference in virulence.
Haggerty CL, Totten PA, Ferris M, et al.: Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect 2009, 85:242–248.
Bebear CM, de Barbeyrac B, Pereyre S, et al.: Activity of Moxifloxacin against the urogenital mycoplasmas, Ureaplasmas spp., Mycoplasmas hominis, Mycoplasma genitalium and Chlamydia trachomatis. Clin Microbiol Infect 2008, 14:801–805.
Guven MA, Gunyeli I, Dogan M, et al.: The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum and the comparison of two medical regimens. Arch Gynecol Obstet 2005, 272:197–200.
• Bjornelius E, Anagrius C, Bojs G, et al.: Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008, 84:72–76. This article describes a study of the microbiological eradication of M. genitalium.
Jernberg E, Moghaddam A, Moi H: Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008, 19:676–679.
Thurman AR, Musatovova O, Perdue S, et al.: Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads. Int J STD AIDS 2010, 21:177–183.
Lanzafame M, Delama A, Lattuada E, et al.: Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. Infez Med 2006, 14:213–215.
Ross JDC, Brown L, Saunders P, et al.: Mycoplasma genitalium in asymptomatic patients: implications for screening. Sex Transm Infect 2009, 85:436–437.
Disclosure
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patel, M.A., Nyirjesy, P. Role of Mycoplasma and Ureaplasma Species in Female Lower Genital Tract Infections. Curr Infect Dis Rep 12, 417–422 (2010). https://doi.org/10.1007/s11908-010-0136-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-010-0136-x